May 9 |
Myriad Genetics First Quarter 2024 Earnings: Beats Expectations
|
May 8 |
Myriad Genetics, Inc. (NASDAQ:MYGN) Q1 2024 Earnings Call Transcript
|
May 8 |
Myriad Genetics (MYGN) Posts Narrower-Than-Estimate Loss in Q1
|
May 8 |
Myriad Genetics surges 17% as Street applauds 2024 guidance, Q1 results
|
May 8 |
Myriad Genetics Inc (MYGN) Q1 2024 Earnings Call Transcript Highlights: Strong Start with ...
|
May 8 |
Myriad Genetics, Inc. (MYGN) Q1 2024 Earnings Call Transcript
|
May 7 |
Myriad (MYGN) Reports Q1 Earnings: What Key Metrics Have to Say
|
May 7 |
Myriad Genetics Reports Q1 2024 Earnings: Revenue Growth Surpasses Estimates Amidst Challenges
|
May 7 |
Myriad Genetics (MYGN) Reports Q1 Loss, Tops Revenue Estimates
|
May 7 |
Myriad Genetics GAAP EPS of -$0.29 beats by $0.01, revenue of $202.2M beats by $8.95M
|